Table 2 The univariable and multivariable analysis of prognostic factors including new grading system and clinicopathologic characteristics.
Prognostic factors | Recurrence-free survival | Overall survival | ||||||
|---|---|---|---|---|---|---|---|---|
Univariable analysis | Multivariable analysis | Univariable analysis | Multivariable analysis | |||||
HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
New Grading system | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Grade 1 vs Grade 3 | 0.113 (0.046–0.277) | <0.001 | 0.165 (0.067–0.409) | <0.001 | 0.099 (0.031–0.313) | <0.001 | 0.134 (0.042–0.428) | 0.001 |
Grade 2 vs Grade 3 | 0.429 (0.316–0.583) | <0.001 | 0.526 (0.383–0.722) | <0.001 | 0.360 (0.244–0.531) | <0.001 | 0.428 (0.287–0.639) | <0.001 |
Age (≥65) | 1.414 (1.046–1.912) | 0.024 | 1.331 (0.983–1.801) | 0.064 | 1.764 (1.229–2.530) | 0.002 | 1.710 (1.191–2.454) | 0.004 |
Sex (Male) | 1.361 (1.019–1.818) | 0.037 | 1.487 (1.041–2.124) | 0.029 | ||||
Smoking history (Smoker) | 1.062 (0.758–1.486) | 0.728 | 1.209 (0.811–1.804) | 0.352 | ||||
Surgery strategy (Sublobar) | 1.066 (0.579–1.961) | 0.837 | 0.757 (0.396–1.446) | 0.757 | ||||
T stage | 0.001 | 0.064 | 0.007 | |||||
T1a vs T2a | 0.219 (0.070–0.690) | 0.009 | 0.381 (0.120–1.217) | 0.103 | 0.217 (0.053–0.884) | 0.033 | ||
T1b vs T2a | 0.491 (0.327–0.738) | 0.001 | 0.764 (0.491–1.187) | 0.231 | 0.478 (0.290–0.790) | 0.004 | ||
T1c vs T2a | 0.951 (0.654–1.382) | 0.791 | 1.296 (0.861–1.949) | 0.213 | 0.858 (0.535–1.377) | 0.526 | ||
Pathological stage (IB) | 1.626 (1.205–2.194) | 0.001 | 1.733 (1.195–2.514) | 0.004 | ||||
Predominant pattern | <0.001 | <0.001 | ||||||
Lepidic vs CG | 0.112 (0.044–0.283) | <0.001 | 0.093 (0.028–0.305) | <0.001 | ||||
Acinar vs CG | 0.565 (0.389–0.820) | 0.003 | 0.456 (0.290–0.717) | 0.001 | ||||
Papillary vs CG | 0.389 (0.234–0.649) | <0.001 | 0.331 (0.175–0.624) | 0.001 | ||||
MP vs CG | 1.514 (0.679–3.375) | 0.311 | 1.421 (0.551–3.664) | 0.468 | ||||
Solid vs CG | 1.500 (0.906–3.375) | 0.115 | 1.572 (0.893–2.769) | 0.117 | ||||
Visceral pleural invasion (Presence) | 2.823 (2.043–3.901) | <0.001 | 1.873 (1.285–2.731) | 0.001 | 2.762 (1.865–4.091) | <0.001 | 1.802 (1.202–2.701) | 0.004 |
Lymphovascular invasion (Presence) | 2.611 (1.820–3.745) | <0.001 | 1.869 (1.296–2.695) | 0.001 | 2.800 (1.826–4.294) | <0.001 | 2.004 (1.300–3.090) | 0.002 |
Pathological tumor size | 1.671 (1.410–1.980) | <0.001 | 1.744 (1.418–2.145) | <0.001 | ||||